GE HealthCare Technologies Inc. $GEHC Shares Sold by State of Michigan Retirement System

State of Michigan Retirement System trimmed its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 76.0% during the third quarter, Holdings Channel reports. The firm owned 123,453 shares of the company’s stock after selling 391,100 shares during the quarter. State of Michigan Retirement System’s holdings in GE HealthCare Technologies were worth $9,271,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Dodge & Cox boosted its holdings in GE HealthCare Technologies by 42.1% during the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after acquiring an additional 6,982,441 shares during the period. Norges Bank acquired a new stake in shares of GE HealthCare Technologies during the second quarter worth about $468,120,000. Holocene Advisors LP grew its holdings in shares of GE HealthCare Technologies by 178.5% in the second quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock valued at $298,306,000 after purchasing an additional 2,581,522 shares in the last quarter. Menora Mivtachim Holdings LTD. purchased a new stake in GE HealthCare Technologies during the 2nd quarter worth approximately $80,755,000. Finally, Balyasny Asset Management L.P. acquired a new position in shares of GE HealthCare Technologies in the second quarter worth $58,388,000. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $80.65 on Monday. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The stock has a market capitalization of $36.76 billion, a price-to-earnings ratio of 17.69, a PEG ratio of 1.75 and a beta of 1.09. The company has a 50-day simple moving average of $82.73 and a 200-day simple moving average of $77.55. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. During the same period in the prior year, the business earned $1.45 EPS. The firm’s revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s payout ratio is currently 3.07%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on GEHC. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $98.00 target price on shares of GE HealthCare Technologies in a report on Friday, January 9th. Jefferies Financial Group boosted their price target on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Stifel Nicolaus increased their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a research report on Wednesday. Finally, Barclays boosted their price target on shares of GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a research report on Friday. Seven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies has an average rating of “Hold” and a consensus target price of $92.50.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.